Neogen Corporation (NASDAQ:NEOG) Given Average Recommendation of “Hold” by Analysts

Posted by Geri Gentry on Jun 6th, 2026

Neogen Corporation (NASDAQ:NEOG – Get Free Report) has received an average recommendation of “Hold” from the six brokerages that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $10.6667.

NEOG has been the topic of a number of analyst reports. William Blair restated a “market perform” rating on shares of Neogen in a report on Monday, March 2nd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Neogen in a research report on Friday, April 10th. Finally, Wall Street Zen raised shares of Neogen from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th.

View Our Latest Stock Report on Neogen

Institutional Investors Weigh In On Neogen

A number of institutional investors have recently added to or reduced their stakes in NEOG. UMB Bank n.a. grew its position in Neogen by 238.2% in the 4th quarter. UMB Bank n.a. now owns 6,422 shares of the company’s stock worth $45,000 after purchasing an additional 4,523 shares in the last quarter. Hantz Financial Services Inc. grew its position in Neogen by 816.9% in the 4th quarter. Hantz Financial Services Inc. now owns 7,592 shares of the company’s stock worth $53,000 after purchasing an additional 6,764 shares in the last quarter. Cresset Asset Management LLC bought a new stake in Neogen in the 2nd quarter worth about $53,000. Evergreen Capital Management LLC bought a new stake in Neogen in the 2nd quarter worth about $56,000. Finally, Northwestern Mutual Wealth Management Co. grew its position in Neogen by 3,158.4% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 8,309 shares of the company’s stock worth $58,000 after purchasing an additional 8,054 shares in the last quarter. 96.73% of the stock is owned by institutional investors.

Neogen Trading Down 2.4%

NEOG opened at $8.90 on Friday. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.92 and a quick ratio of 2.84. Neogen has a fifty-two week low of $4.56 and a fifty-two week high of $11.43. The firm has a market capitalization of $1.94 billion, a PE ratio of -3.18, a P/E/G ratio of 4.08 and a beta of 1.80. The company’s 50-day moving average is $9.16 and its 200 day moving average is $8.84.

Neogen (NASDAQ:NEOG – Get Free Report) last posted its earnings results on Thursday, April 9th. The company reported $0.09 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.05. Neogen had a negative net margin of 69.93% and a positive return on equity of 2.35%. The company had revenue of $211.20 million for the quarter, compared to analyst estimates of $204.62 million. The company’s quarterly revenue was down 4.4% compared to the same quarter last year. As a group, research analysts predict that Neogen will post 0.23 earnings per share for the current fiscal year.

About Neogen

(Get Free Report)

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.